# active_site_0116

[All 1,736 questions](../README.md) · [Method and limits](../METHOD.md) · [Source credits](../THIRD_PARTY_NOTICES.md)

**Task:** `active_site`  
**Author expected answer:** **A** — Position 83 (Acyl-ester intermediate)

| Expected-answer support | Reasoning versus lookup | Review status |
|---|---|---|
| supported | reasoning-supported | format-valid AI review |

These labels are Luna’s original judgments. Source support and reasoning from the original input are separate questions. The benchmark key and original score are unchanged.

## Complete original question

The sequence and choices below are the complete original user message, in their original order.

```text
[Protein Sequence]
MKLLKILSLVCLSISIGACAEHSMSRAKTSTIPQVNNSIIDQNVQALFNEISADAVFVTYDGQNIKKYGTHLDRAKTAYIPASTFKIANALIGLENHKATSTEIFKWDGKPRFFKAWDKDFTLGEAMQASTVPVYQELARRIGPSLMQSELQRIGYGNMQIGTEVDQFWLKGPLTITPIQEVKFVYDLAQGQLPFKPEVQQQVKEMLYVERRGENRLYAKSGWGMAVDPQVGWYVGFVEKADGQVVAFALNMQMKAGDDIALRKQLSLDVLDKLGVFHYL

[Multiple Choices]
A. Position 83 (Acyl-ester intermediate)
B. Position 735 (For beta-ketoacyl synthase activity)
C. Position 234 (Proton donor)
D. Position 241 (Lowers pKa of active site Tyr)
```

<details>
<summary>Original system instructions, verbatim</summary>

```text
You are an excellent scientist. Analyze the provided protein-related task carefully and choose the correct answer from the multiple-choice options.

The current task is about Enzyme Active Site Prediction, which is to identify the key amino acid residues that form the active site of an enzyme. The active site is the specific region on the enzyme where a substrate binds and the chemical reaction is catalyzed. Based on the full protein sequence provided, you must select the option that correctly lists the amino acid residues (by their type and position) that constitute the enzyme's catalytic center.. The inputs provided by the user for this task include:

* Protein Sequence: The amino acid sequence of the protein.
* Multiple Choices: Candidate answers for the protein-related question.

Please think step-by-step about this problem:
1. Analyze the protein sequence carefully.
2. Consider the biological context and function.
3. Evaluate each multiple-choice option.
4. Provide your reasoning process.
5. Finally, give your answer.

Provide your response in the following format:
1. reasoning: [Your detailed reasoning here]
2. answer: Your final answer, which should be "A", "B", "C" or "D".
```

</details>

## Luna’s full visible review

### Expected-answer support: supported

> The sequence matches OXA-58, and the matched UniProt record annotates residue 83 as the acyl-ester intermediate, with evidence citing both a PubMed study and a PDB structure. This supports choice A, while preserving that the annotation combines evidence sources rather than representing a single independently reviewed experiment here.

Cited evidence: [C1](#evidence-c1), [C5](#evidence-c5), [C6](#evidence-c6), [H5](#evidence-h5), [H6](#evidence-h6).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> The sequence contains the conserved SXXK motif of serine beta-lactamases (STFK); its serine is the nucleophile that forms an acyl-enzyme intermediate during beta-lactam hydrolysis. The motif’s serine is at position 83, supporting choice A. Choice B also names a position beyond this 280-residue sequence.

**Missing item-specific fact**

> Experimental or database confirmation of this particular protein’s residue-83 role is absent from the input, but the conserved sequence motif and its established chemistry meaningfully distinguish A.

**Reason**

> The active-site chemistry is supported by a recognizable conserved motif in the supplied sequence, not merely by recognizing the exact sequence or recalling an annotation.

### Question ambiguity

**Multiple defensible options named by Luna:** none.

> The sequence motif and the stated acyl-enzyme role support A; the other options are inconsistent with the sequence length or the motif’s expected chemistry.

### Important caveats

- The reviewer-only UniProt and structural evidence was not supplied to the evaluated model and is used only to assess whether the key is supported.
- The exact sequence match and residue numbering refer to the canonical 280-residue entry; construct or isoform numbering is not assumed.

<details>
<summary>Saved visible review as JSON</summary>

```json
{
  "case_id": "active_site_0116",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The sequence matches OXA-58, and the matched UniProt record annotates residue 83 as the acyl-ester intermediate, with evidence citing both a PubMed study and a PDB structure. This supports choice A, while preserving that the annotation combines evidence sources rather than representing a single independently reviewed experiment here.",
    "evidence_ids": [
      "C1",
      "C5",
      "C6",
      "H5",
      "H6"
    ]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "The sequence contains the conserved SXXK motif of serine beta-lactamases (STFK); its serine is the nucleophile that forms an acyl-enzyme intermediate during beta-lactam hydrolysis. The motif’s serine is at position 83, supporting choice A. Choice B also names a position beyond this 280-residue sequence.",
    "missing_item_specific_fact": "Experimental or database confirmation of this particular protein’s residue-83 role is absent from the input, but the conserved sequence motif and its established chemistry meaningfully distinguish A.",
    "reason": "The active-site chemistry is supported by a recognizable conserved motif in the supplied sequence, not merely by recognizing the exact sequence or recalling an annotation."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The sequence motif and the stated acyl-enzyme role support A; the other options are inconsistent with the sequence length or the motif’s expected chemistry."
  },
  "important_caveats": [
    "The reviewer-only UniProt and structural evidence was not supplied to the evaluated model and is used only to assess whether the key is supported.",
    "The exact sequence match and residue numbering refer to the canonical 280-residue entry; construct or isoform numbering is not assumed."
  ]
}
```

</details>

## Project source-check notes

These project-authored, AI-assisted checks assess specific source claims. They are not expert adjudication and do not replace Luna’s saved review or the author key.

No additional case-specific project note was recorded. Citation membership checks do not establish that every scientific argument is correct.

## Reviewer-only source evidence

**This source material was supplied only to the reviewer. It was absent from the original evaluated question.** An exact-sequence database match can support a key without establishing that the question can be answered by reasoning from its original input.

**Accession:** `Q2TR58`; identity was recovered from dataset image-path metadata and was absent from the evaluated model input.  
**Sequence applicability:** historical matched; current matched.  
**Historical cutoff:** 2026-05-07; selected entry version 133. The exact author source snapshot remains unknown.

- All evidence and source identity in this section are reviewer-only and were absent from the evaluated model input.
- UniProt annotations may be experimental, computational, or transferred by similarity; evidence codes and qualifiers are retained.
- The 2026-05-07 cutoff approximates the pinned repository date; the author data-construction date and exact source snapshot remain unknown.
- Selected source fields are excerpts; missing annotation is not evidence of falsehood. Primary papers were not comprehensively retrieved or independently validated.

### Evidence C1

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/Q2TR58.json)  
**Locator:** `/primaryAccession`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:30:39.664161+00:00.  

```json
"Q2TR58"
```

Source SHA-256: `90800739268b3a91a720a2ca6b56cd2e1f1fdaaa169bc64ee8999ea5771dcb35`.

### Evidence C5

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/Q2TR58.json)  
**Locator:** `/features/2`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:30:39.664161+00:00.  

```json
{"description":"Acyl-ester intermediate","evidences":[{"evidenceCode":"ECO:0000255","id":"PIRSR602137-50","source":"PIRSR"},{"evidenceCode":"ECO:0000269","id":"26459904","source":"PubMed"},{"evidenceCode":"ECO:0007744","id":"4Y0U","source":"PDB"}],"location":{"end":{"modifier":"EXACT","value":83},"start":{"modifier":"EXACT","value":83}},"type":"Active site"}
```

Source SHA-256: `90800739268b3a91a720a2ca6b56cd2e1f1fdaaa169bc64ee8999ea5771dcb35`.

### Evidence C6

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/Q2TR58.json)  
**Locator:** `/features/3`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:30:39.664161+00:00.  

```json
{"description":"","evidences":[{"evidenceCode":"ECO:0000269","id":"26459904","source":"PubMed"},{"evidenceCode":"ECO:0007744","id":"4Y0U","source":"PDB"}],"featureCrossReferences":[{"database":"ChEBI","id":"CHEBI:35627"}],"ligand":{"id":"ChEBI:CHEBI:35627","name":"a beta-lactam"},"location":{"end":{"modifier":"EXACT","value":83},"start":{"modifier":"EXACT","value":83}},"type":"Binding site"}
```

Source SHA-256: `90800739268b3a91a720a2ca6b56cd2e1f1fdaaa169bc64ee8999ea5771dcb35`.

### Evidence H5

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/Q2TR58?format=txt&versions=133)  
**Locator:** `lines 457-460`  
**Scope:** record released no later than 2026-05-07; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Entry / sequence version:** 133 / 1.  
**Retrieved:** 2026-11-02T04:30:42.289456+00:00.  

```text
FT   ACT_SITE        83
FT                   /note="Acyl-ester intermediate"
FT                   /evidence="ECO:0000255|PIRSR:PIRSR602137-50,
FT                   ECO:0000269|PubMed:26459904, ECO:0007744|PDB:4Y0U"
```

Source SHA-256: `866adbe4a25883d784b4da01795f3c6d0f8328c05c58ea698350889ad138c921`.

### Evidence H6

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/Q2TR58?format=txt&versions=133)  
**Locator:** `lines 461-465`  
**Scope:** record released no later than 2026-05-07; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Entry / sequence version:** 133 / 1.  
**Retrieved:** 2026-11-02T04:30:42.289456+00:00.  

```text
FT   BINDING         83
FT                   /ligand="a beta-lactam"
FT                   /ligand_id="ChEBI:CHEBI:35627"
FT                   /evidence="ECO:0000269|PubMed:26459904,
FT                   ECO:0007744|PDB:4Y0U"
```

Source SHA-256: `866adbe4a25883d784b4da01795f3c6d0f8328c05c58ea698350889ad138c921`.

---

Question and key: [LiveProteinBench source](https://github.com/Rongdingyi/LiveProteinBench/blob/8b9710932511f816651fc1a7e8a1bc85c3c77767/dataset/QA/active_site.json) (zero-based source row 116). Benchmark content © 2026 LiveProteinBench contributors, [CC BY 4.0](https://huggingface.co/datasets/LiveProteinBench/LiveProteinBench/blob/8428f64e33d53330f7745376d9c45de2d2c37eaf/LICENSE). Cited UniProt / Gene Ontology excerpts retain their own attribution; see [source credits](../THIRD_PARTY_NOTICES.md).
